Answer
Combination therapies with bortezomib, lenalidomide, pomalidomide and/or dexamethasone do not affect belantamab mafodotin pharmacokinetics, although no drug interaction studies have been performed.
Sources for this answer
- Blenrep 100mg & 70 mg powder for concentrate for solution for infusionGlaxoSmithKline UK · emc · SmPC §4.5 Interaction with other medicinal products · Version 2Document updated
Sources checked